. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Ann Hematol. 2016 Jan 9;95(4):575–580. doi: 10.1007/s00277-016-2588-z

Table 3.

Risk factors for hematological malignancies in HIV patients (n = 10,221)

Characteristic	HM positive (n = 229)	HM negative (n = 9992)	p value
Male, %	160 (70)	5760 (57.6)	0.0001
Prescribed HAART, %	141 (61.6)	5489 (54.9)	0.046
Hepatitis C
Number of patients tested for HCV co–infection	204 (89.1 %)	8879 (88.9 %)	0.916
Serology positive or viral load detectable HCV/total number tested	70/204 (34.3 %)	3299/ 8879 (37.2 %)	0.420
Hepatitis B
Number of patients tested for HBV co–infection	202 (88.2 %)	8652 (86.6 %)	0.476
HBsAg positive / total number tested	18/202 (9 %)	580/8652 (6.7 %)	0.201
SPEP
Number tested	76 (33.2 %)	1295 (13 %)	0.0001
SPEP positive of those tested	17 /76 (22.4 %)	244/ 1295 (18.8 %)	0.453
Faint paraprotein of those tested	12/76 (15.8 %)	217/1295 (16.8 %)	1.000
Discrete paraprotein of those tested	5/76 (6.6 %)	27/ 1295 (2.1 %)	0.028